Financials.page
Company Fundamentals
Workspace
OverviewhomeCompaniesdirectoryLeague tablesrankingsAPI & MCPdevelopers
Company financial data, refreshed daily. Not investment advice.
Financials.page — company financial data, refreshed daily. Not investment advice. Legal & terms
Annual figures as reported in 10-K / 20-F / 40-F filings.
INBS · CIK 0001725430

Intelligent Bio Solutions Inc.

Annual figures as reported, FY2019–FY2026. Ratios and growth rates derived on-page.

INBS logo
Surgical & Medical Instruments & Apparatus
Company profile
Nasdaq · INBSHQ New York, NYIncorporated in DEFiscal year ends Jun 30Non-accelerated filer Smaller reporting company
Revenue
$4.2M
▲ +38.1% vs FY2025
Net income
−$12.4M
▼ −17.6% vs FY2025
Free cash flow
−$12.1M
▼ −21.6% vs FY2025
Diluted EPS
−$8.44
▲ +57.9% vs FY2025

Revenue

Annual, as reported

02M4M’20’22’24’26$4.2M

Net income

Losses shown in terracotta

−10M−5M0’20’22’24’26−$12.4M

Recent quarters

momentum · last 12 quarters
Revenue — Jun ’26 quarter
$1.1M
▲ +35.8% vs Jun ’25
Net income — Jun ’26 quarter
−$3.9M
▼ −26.5% vs Jun ’25
Revenue — trailing 12 months
$4.2M
▲ +38.1% vs Jun ’25
Diluted EPS — trailing 12 months
−$53.17
▲ +52.0% vs Jun ’25

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

0500K1MSep ’23Mar ’24Sep ’24Mar ’25Sep ’25Mar ’26Jun ’26$1.1M

Quarterly net income

Losses shown in terracotta

−3M−2M−1M0Sep ’23Mar ’24Sep ’24Mar ’25Sep ’25Mar ’26Jun ’26−$3.9M
QuarterRevenueRev. YoYGross marginNet incomeNet marginDiluted EPS
Jun ’26$1.1M35.8%46.8%−$3.9M−341.0%−$3.47
Mar ’26$1.1M45.5%50.5%−$2.9M−269.9%−$18.00
Dec ’25$897K47.6%51.3%−$2.7M−298.6%−$28.20
Sep ’25$1.1M27.5%46.6%−$3.0M−268.3%−$3.50
Jun ’25$844K15.9%39.8%−$3.1M−366.2%−$9.97
Mar ’25$729K−11.5%46.8%−$2.5M−349.0%−$44.10
Dec ’24$607K−20.5%36.7%−$2.2M−370.3%−$49.60
Sep ’24$872K9.6%39.8%−$2.7M−307.9%−$7.00

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

-1500%-1000%-500%0%’20’22’24’26
Gross marginOperating marginNet margin

Returns on capital

Net income vs year-end equity and assets

-300%-200%-100%0%’20’22’24’26
Return on equityReturn on assets

Cash flow

cash generation

Free cash flow

Operating cash flow less capital expenditure

−10M−5M0’24’25’26−$12.1M

Operating cash flow

Net cash from operations

−10M−5M0’20’22’24’26−$11.9M

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

0500K1M’21’22’23’24’25’261M

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

010M’19’21’23’25’26$5.5M

Growth rates

compounding, annualized

Income statement

CAGR over 3, 5 and 10 years

0%+10%+20%+30%+40%Revenue CAGR3Y+49.7%5Y+16.3%

Cash flow & share count

FCF compounding; share count as total change

0%+1000%+2000%Share count change (split-adjusted, total)5Y+2728.2%

Key ratios

derived per fiscal year
Fiscal yearGross marginOp. marginNet marginFCF marginROEROACurrent ratioDebt / equity
FY202648.6%−299.1%−294.9%−285.9%−225.6%−104.1%1.44×—
FY202540.8%−349.8%−346.2%−324.6%−352.7%−128.1%0.77×—
FY202445.8%−330.5%−326.4%−314.7%−121.9%−73.7%1.57×0.20×
FY202326.0%−1002.1%−845.9%—−279.9%−102.7%0.66×—
FY2022—−1907.1%−1900.1%—−125.4%−67.2%2.33×—
FY2021—−281.4%−355.3%—−46.7%−32.2%4.94×—
FY2020—−1513.7%−1676.2%——−127.8%0.30×—
FY2019————————

Annual figures

as reported
Fiscal yearRevenueGross profitOp. incomeNet incomeDiluted EPSOp. cash flowCapexTotal assetsLiabilitiesEquityCashLT debt
FY2026$4.2M$2.0M−$12.6M−$12.4M−$8.44−$11.9M$126K$11.9M$6.7M$5.5M$4.0M—
FY2025$3.1M$1.2M−$10.7M−$10.6M−$20.04−$9.7M$232K$8.2M$5.4M$3.0M$1.0M—
FY2024$3.1M$1.4M−$10.3M−$10.2M−$63.80−$9.6M$221K$13.8M$5.6M$8.3M$6.3M$1.6M
FY2023$1.3M$327K−$12.6M−$10.6M−$1270.00−$7.4M—$10.4M$6.7M$3.8M$1.5M—
FY2022$437K—−$8.3M−$8.3M−$113.30−$3.4M—$12.4M$5.8M$6.6M$8.2M—
FY2021$2.0M—−$5.6M−$7.0M−$136.00−$11.3M—$21.9M$6.9M$15.1M$12.6M—
FY2020$189K—−$2.9M−$3.2M−$74.00−$499K—$2.5M$7.7M−$5.2M$427K—
FY2019—————————−$4.0M——

Latest filings

the most recent regulatory filings
8-KCurrent report — material event2026-08-19 ↗10-KAnnual report2026-08-19 ↗SCHEDULE 13G/ASEC filing2026-08-14 ↗8-KCurrent report — material event2026-08-11 ↗8-KCurrent report — material event2026-08-05 ↗8-KCurrent report — material event2026-08-03 ↗8-KCurrent report — material event2026-08-03 ↗8-KCurrent report — material event2026-07-23 ↗8-KCurrent report — material event2026-07-21 ↗8-KCurrent report — material event2026-06-16 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.